26
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage

, , , , , , & show all
Pages 356-360 | Received 26 Jan 2004, Accepted 15 Jun 2004, Published online: 02 Jan 2014

References

  • Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Ftiel PL. The relationship between disease activity, joint destruc-tion, and functional capacity over the course of rheumatoid arthri-tis. Arthritis Rheum 2001;44:2009–17.
  • Chen H, Deere M, Hecht JT, Lawler J. Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes. J Biol Chem 2000;275: 26538–44.
  • Oldberg A, Antonsson P, Lindblom K, Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992;267:22346–50.
  • Rosenberg K, Olsson H, Morgelin M, Heinegard D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent inter-action with triple helical collagen. J Biol Chem 1998;273:20397–403.
  • Thur J, Rosenberg K, Nitsche DP, Pihlajamaa T, Ala-Kokko L, Heinegird D, et al. Mutations in cartilage oligomeric matrix pro-tein causing pseudoachondroplasis and multiple epiphyseal dyspla-sia affect binding of calcium and collagen 1,11, and IX. J Biol Chem 2001;276: 6083–92.
  • Holden P, Meadows RS, Chapman KI, Grant ME, Kadler KE, Briggs MD. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a patho-genetic mechanism in a bone dysplasia family. J Biol Chem 2001; 276:6046–55.
  • Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, et al. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics 1994;24:435–9.
  • Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins: an acidic oligo-meric protein (COMP) detected only in cartilage. J Biol Chem 1992;267:6132–6.
  • Saxne T, Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Ftheumatol 1992;31:583–91.
  • Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, et al. Serum matrix metalloproteinase-3 as a predic-tor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852–8.
  • Ochi T, Iwase R, Yonemasu K, Matsukawa M, Yoneda M, Yukioka M, et al. Natural course of joint destruction and fluctua-tion of serum Clq levels in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:37–43.
  • Larsen A. A radiological method for grading the severity of rheu-matoid arthritis. Scand J Ftheumatol 1975;4:225–33.
  • Forslind K, Eberhardt K, Jonsson A, Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein: a prognostic marker in early rheumatoid arthritis. Br J Ftheumatol 1992;31:593–8.
  • Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligo-meric matrix protein: a predicting factor and a valuable parame-ter for disease management in rheumatoid arthritis. Scand J Ftheumatol 2003;32:156–61.
  • Crnkic M, Mansson B, Larsson L, Geborek P, Heinegard D, Saxne T. Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 2003;5:R181–5.
  • Roux-Lombard P, Eberhardt K, Saxne T, Dayer JM, Wollheim FA. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis; a prospective 5-year study. Ftheumatology (Oxford) 2001;40: 544–51.
  • Fex E, Eberhardt K, Saxne T. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. Br J Ftheumatol 1997;36:1161–5.
  • Mansson B, Geborek P, Saxne T. Cartilage and bone macro-molecules in knee joint synovial fluid in rheumatoid arthritis: rela-tion to development of knee or hip joint destruction. Ann Rheum Dis 1997;56:91–6.
  • Wollheim FA, Eberhardt KB, Johnson U, Saxne T. HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predic-tors of joint destruction in recent-onset rheumatoid arthritis. Br J Rheumatol 1997;36:847–9.
  • Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degra-dation. Br J Ftheumatol 1997;36:1151–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.